Comparison of Efficacy and Safety of Different Guided Technologies Combined With Ultrathin Bronchoscopic Biopsy for Peripheral Pulmonary Lesions
The Clinical Respiratory Journal · 2024
DOI: 10.1111/crj.70012 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Clinical Respiratory Journal, 2024. Verfasst von Zhihan Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Bronchoscopy, Tomography, X-Ray Computed. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Guangdong Province, Shenzhen Science and Technology Innovation Commission Foundation, Key Program for Clinical Research at Peking University Shenzhen Hospital.
Abstract (Originalsprache)
Introduction
Various bronchoscopic guidance techniques have emerged to improve the diagnostic yield of peripheral pulmonary lesions (PPLs), especially when combined with ultra‐thin bronchoscopy. However, uncertainties exists in the convenience, accuracy rate, and complications of these techniques. We compared the feasibility, accuracy rate, and complication rates of transbronchial biopsy of PPLs sampled by the standard thin‐layer CT navigation combined with ultrathin bronchoscopy (CTNUTB), the Lungpro virtual navigation combined with ultrathin bronchoscopy (VNUTB), and electromagnetic navigation combined with ultrathin bronchoscopy (ENUTB).
Methods
Retrospectively identified were 256 patients sampled with transbronchial biopsy of PPLs. Eligible patients referred for CTNUTB, VNUTB, and ENUTB from January 2017 to December 2021 were included. We comprehensively compared the accuracy rate, feasibility, and complication rates for each method.
Results
There was no significant difference in the accuracy rate of CTNUTB, VNUTB, and ENUTB ( p = 0.293). The operation time via Lungpro navigation was the shortest (14.4 min, p < 0.001). The planning time via CT planning was the shortest (7.36 min, p < 0.001). There was no difference in the incidence of complications such as hemorrhage, pneumonia, and pneumothorax ( p = 0.123). Besides, ENUTB costs more than $2000, while CTNUTB and VNUTB cost only about $130–230.
Conclusion
CTNUTB is still the main bronchoscopy method we recommended, which has low cost, simple operation, and safety no less than the others. In contrast, ENUTB provides a higher accuracy rate for small diameter nodules (less than 2 cm), which has a high use value and is worth promoting in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
- Peking University Health Science Center, Beijing, China.
- Shantou University Medical College, Shantou, Guangdong, China.
- University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Zhihan Zhang
Förderung
- Natural Science Foundation of Guangdong Province
- Shenzhen Science and Technology Innovation Commission Foundation
- Key Program for Clinical Research at Peking University Shenzhen Hospital
Zitieren
APA
Zhang, Z., Zhang, J., Chen, X., Yan, J., Zeng, C., & Xu, P. (2024). Comparison of Efficacy and Safety of Different Guided Technologies Combined With Ultrathin Bronchoscopic Biopsy for Peripheral Pulmonary Lesions. The Clinical Respiratory Journal. https://doi.org/10.1111/crj.70012
Vancouver
Zhang Z, Zhang J, Chen X, Yan J, Zeng C, Xu P. Comparison of Efficacy and Safety of Different Guided Technologies Combined With Ultrathin Bronchoscopic Biopsy for Peripheral Pulmonary Lesions. The Clinical Respiratory Journal. 2024. doi:10.1111/crj.70012
BibTeX
@article{Zhang2024,
author = {Zhang, Zhihan and Zhang, Junbao and Chen, Xi and Yan, Junfeng and Zeng, Cao and Xu, Ping},
title = {Comparison of Efficacy and Safety of Different Guided Technologies Combined With Ultrathin Bronchoscopic Biopsy for Peripheral Pulmonary Lesions},
journal = {The Clinical Respiratory Journal},
year = {2024},
doi = {10.1111/crj.70012}
}
EUVIMED